Share Name Share Symbol Market Type Share ISIN Share Description
Finsbury Food Group Plc LSE:FIF London Ordinary Share GB0009186429 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 81.50 80.00 83.00 0.00 0.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 303.6 4.5 1.7 47.9 104

Finsbury Food Share Discussion Threads

Showing 4526 to 4549 of 4550 messages
Chat Pages: 182  181  180  179  178  177  176  175  174  173  172  171  Older
DateSubjectAuthorDiscuss
17/10/2019
16:36
SP showing a little life again
spaceparallax
03/10/2019
09:47
ALL that selling and yet the stock is creeping higher. Interesting that ;-) Perhaps this is one of the handful of stocks that can outperform the chaos in the wider market.
sphere25
30/9/2019
12:11
Lots of chunky selling going onSicknote
s34icknote
23/9/2019
08:19
Some whopping big volume exchanges last week with significant volume on both Thursday and Friday. Clearly serious interest in the background as the volume on Friday of over 10m is the largest since 2013.
sphere25
18/9/2019
12:20
Ok folks, further to the post below, I'm accumulating stock. Stock is hard to get hold of, but there is too much value to ignore. There is alot of demand coming in from other buyers too. Edit: Price has got away abit. Price spiked shortly after this post. Wait for a pullback now. ------------------------------------------------------------------------------- Sphere25 16 Sep '19 - 12:03 - 2048 of 2056 Edit 0 0 0 Yes, this one looks interesting as it has already been...err... creamed from over 120. - Strong growth in H2 with continued confidence into the new year - Net debt has risen primarily because: "On 3 September 2018 the Group acquired the entire share capital of Ultrapharm Limited (Ultrapharm) for £16.9m" Also, costs relating to closure of bakeries and acquisitions of about £3.5m Unsure how many more exceptionals to come, but with capex expected to fall (see below), there is a nice chunk of operating cashflow to cover the capex and the dividend, so debt should come down gradually. "With the Group now in its strongest position in recent years and having completed a period of intense investments including the IT platform roll out and the new Free From bakery in Poland, we are expecting to significantly reduce our capital spend going forward as we focus on driving further efficiencies from the new systems and processes and utilise our additional capacity" So with the strongest position in years, growth to come, a single digit p/e and a yield of 5%, there does appear to be a fair bit of doom and gloom priced in here. Once more, it boils down to the length of political meddling and whether that affects things here materially or whether the worst is now in, particularly considering the already resilient performance. I'm certainly tempted!
sphere25
18/9/2019
07:00
Good performance Line drawn under previous ‘investment217; period Can’t stand still though... will be looking for acquisitions and will be well placed to buy given it’s 10 year record I like it, but it mmust keep the pedal pressed
jpjp100
17/9/2019
13:13
I think they made quite a profit on the sale and were keen to re enter the mkt when the exclusion agreement expired.
spaceparallax
17/9/2019
12:46
Agreed. Very strong management in a tough environment. The only thing that I never really understood is why they sold their gluten free brand, only then to buy another a few years later. Anyone understand?
topvest
17/9/2019
12:32
The Management has been exceptionally good over the last decade - they've really stabilized the finances, improved efficiency and shown vision in pursuing complementary opportunities.
spaceparallax
17/9/2019
11:12
Looks a steady ship . Good div and expansion. Doubled up yesterday after results .Sicknote
s34icknote
16/9/2019
17:44
An excellent contrarian buy signal I feel...
cwa1
16/9/2019
17:18
long term chart IMO looking iffy results did not impress me much
buywell3
16/9/2019
12:35
Always a solid performer in my view. Results are pretty good. Much better value than it was.
topvest
16/9/2019
12:03
Yes, this one looks interesting as it has already been...err... creamed from over 120. - Strong growth in H2 with continued confidence into the new year - Net debt has risen primarily because: "On 3 September 2018 the Group acquired the entire share capital of Ultrapharm Limited (Ultrapharm) for £16.9m" Also, costs relating to closure of bakeries and acquisitions of about £3.5m Unsure how many more exceptionals to come, but with capex expected to fall (see below), there is a nice chunk of operating cashflow to cover the capex and the dividend, so debt should come down gradually. "With the Group now in its strongest position in recent years and having completed a period of intense investments including the IT platform roll out and the new Free From bakery in Poland, we are expecting to significantly reduce our capital spend going forward as we focus on driving further efficiencies from the new systems and processes and utilise our additional capacity" So with the strongest position in years, growth to come, a single digit p/e and a yield of 5%, there does appear to be a fair bit of doom and gloom priced in here. Once more, it boils down to the length of political meddling and whether that affects things here materially or whether the worst is now in, particularly considering the already resilient performance. I'm certainly tempted!
sphere25
16/9/2019
09:35
Very impressive results - especially so in these difficult times. The mkt response speaks volumes and is likely to continue as the news spreads.
spaceparallax
16/9/2019
07:27
AS buywell reads these results Profit is down circa 9% on 2018 and The Group's total net debt is up to £35.6 million (2018: £15.6 million), up £20.0 million from the prior year.
buywell3
27/7/2019
12:24
I have bought in here on Friday because it looks far too cheap and the business has not let margins slip in a really tough trading environment so as this starts to ease and because of the massive capital renewal I really think this can kick on. 9x pe target price so 87 pence. Nice defensive stock if the market wobbles And as a leading UK independent baker I wonder if anyone is running the rule over these guys at these levels
studentinvestor13
18/7/2019
07:46
Strong TS I think the previous sale was ok at the price achieved Ultrapharm could end up being better by helping get things going outside the UK
jpjp100
15/7/2019
13:49
SR, you're not wrong about the sale but they did obtain a decent price; presumably their agreement to self-exclude from that sector has now expired.
spaceparallax
15/7/2019
13:48
Too true TopV, sadly it reflects the broken nature of our marketplace that is open to manipulation and does little to reflect intrinsic value.
spaceparallax
15/7/2019
12:38
Am I wrong in thinking that FIF sold its 'growth' gluten free business about three years ago and has now bought another? Seems a bit strange - an admission of a strategic error or a good deal financially? But I agree that this looks way too cheap now - especially after this pretty upbeat update - and have bought back in after (for the record) having departed in Nov 16 with a modest 20% profit after a year.
srichardson8
15/7/2019
12:04
Yes, very odd that this has been so weak. Nothing has really changed versus when it was twice the price.
topvest
15/7/2019
11:43
A very impressive TS that should cement investor confidence and a return to a more sensible share price
spaceparallax
01/5/2019
17:31
Wrong thread
spaceparallax
Chat Pages: 182  181  180  179  178  177  176  175  174  173  172  171  Older
Your Recent History
LSE
FIF
Finsbury F..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191023 06:10:13